Vyfemla Kit
Product Images NDC 68180-875

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vyfemla (NDC 68180-875). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (7c997649 6fa2 48bc Abfc D3963122a5f5 01)

Chemical structures of Norethindrone and Ethinyl Estradiol are shown, including their molecular formulas and molecular weights. Norethindrone is represented with a molecular weight of 298.4 and formula C20H26O2. Ethinyl Estradiol is shown with a molecular weight of 296.40 and formula C20H24O2.*

FDA Label Image

Fig-2 (7c997649 6fa2 48bc Abfc D3963122a5f5 02)

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Women-Years by Age, Smoking Status and Oral Contraceptive Use' showing mortality rates by age groups 15-24, 25-34, 35-44, and 45+, categorized by ever-users and control groups among nonsmokers and smokers. The vertical axis represents mortality rate as number of deaths per 100,000 woman users, ranging from 0 to 250.*

FDA Label Image

Fig-3 (7c997649 6fa2 48bc Abfc D3963122a5f5 03)

An instructional diagram for Vyfemla showing a weekly day label strip with circles labeled Sunday through Saturday, organized into four rows representing four weeks. It includes arrows indicating pill-taking order and instructions for starting on the correct day depending on the menstrual cycle. The diagram also references a monthly self-breast exam reminder.*

FDA Label Image

Fig-4 (7c997649 6fa2 48bc Abfc D3963122a5f5 04)

Vyfemla 0.4 mg/0.035 mg oral tablets label by Lupin Pharmaceuticals, Inc. The label displays the proprietary name Vyfemla, the active ingredients norethindrone and ethinyl estradiol, and the strength. It includes directions for use with day and week cycle markings and storage instructions at 25°C (77°F). Distribution is by Lupin Pharmaceuticals, Inc., and manufacturing by Lupin Limited in India. The label also features a barcode and space for lot number and expiration date.*

FDA Label Image

Fig-5 (7c997649 6fa2 48bc Abfc D3963122a5f5 05)

Vyfemla tablets USP with active ingredients norethindrone and ethinyl estradiol, dosage strength 0.4 mg/0.035 mg. The label indicates the product is intended as oral contraceptive and is supplied by Lupin Pharmaceuticals, Inc. Packaging contains 1 blister of 28 tablets and includes a barcode and prescription-only warning.*

FDA Label Image

Fig-6 (7c997649 6fa2 48bc Abfc D3963122a5f5 06)

Packaging label for Vyfemla tablets containing 0.4 mg norethindrone and 0.035 mg ethinyl estradiol, labeled as USP. The label shows the product is supplied by Lupin Pharmaceuticals, Inc. It indicates the product is prescription only and comes as a package of 3 tablets. The label includes barcodes, NDC 68180-875-73, and distributor and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.